Frontage Holdings Opens Fully Operational GMP Facility with Advanced Manufacturing Capabilities
I'm PortAI, I can summarize articles.
Frontage Holdings Corporation has launched a new GMP facility, operational since October 2025, enhancing its pharmaceutical development and manufacturing capabilities. The facility includes advanced equipment for aseptic filling, tablet pressing, and more, supporting clinical and small-scale commercial production of various dosage forms. This expansion aims to provide efficient manufacturing solutions for small and mid-sized pharmaceutical companies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments